Stq-peptides

C - Chemistry – Metallurgy – 07 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07K 7/08 (2006.01) A61K 38/10 (2006.01) A61P 9/10 (2006.01) A61P 35/00 (2006.01) A61P 35/04 (2006.01)

Patent

CA 2520372

The invention describes methods for inhibiting angiogenesis in a tissue by administering an antagonist that specifically binds to a proteolyzed or denatured laminin with substantially greater affinity than to the native form of laminin. Methods utilizing such antagonists for therapeutic treatment of tumor growth, tumor metastasis or of restenosis also are described, as are methods to use such antagonists as diagnostic markers of angiogenesis in normal or diseased tissues both in vivo and ex vivo.

L'invention concerne des procédés permettant d'inhiber l'angiogenèse dans un tissu. Lesdits procédés consistent à administrer un antagoniste qui se fixe de manière spécifique sur une laminine protéolysée ou dénaturée présentant une affinité sensiblement supérieure à la forme native de laminine. L'invention concerne également des procédés d'utilisation desdits antagonistes dans le traitement thérapeutique de la croissance tumorale, des métastases tumorales ou de la resténose. L'invention concerne également des procédés d'utilisation desdits antagonistes en tant que marqueurs diagnostiques de l'angiogenèse dans des tissus sains ou malades, in vivo et ex vivo.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Stq-peptides does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Stq-peptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Stq-peptides will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2014198

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.